Evaluation of The Effect of Virtual Reality Glasses

Not yet recruiting

• Conditions: Anxiety; Cancer; Treatment Compliance; Chemotherapy; Virtual Reality

• Registration Number: NCT06474780
• Lead Sponsor: Gozde Oz

Brief Summary

The study was planned as a randomized controlled study to evaluate the effect of virtual reality glasses used on anxiety and treatment compliance in outpatient cancer patients receiving chemotherapy. The sample of the study consisted of a total of 30 patients, including 15 experimental and 15 control groups, who received intravenous chemotherapy treatment every 21 days between April 1 and September 31, 2023, in the outpatient chemotherapy unit of a research hospital. Research data will be collected using the Patient Information Form, Beck Anxiety Scale (BAI) and Chronic Disease Adaptation Scale (CCDS). In evaluating the data, it was planned to analyze the differences between the rates of categorical variables in independent groups with Chi-Square tests. It was planned to use t tests to compare quantitative continuous data between two independent groups. Dependent groups t-test will be used to compare measurements within groups. After being informed about the research, patients in both groups will be given a pre-test. Patients in the experimental group will be shown 3 different videos with virtual reality glasses during 3 cycles of chemotherapy treatment, and a final test will be administered to both groups at the end of the 3rd cycle..

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-05-24
• Status Verified: 2024-06
• Study First Submitted QC: 2024-06-19
• Last Update Submitted: 2024-06-19
• Study First Posted: 2024-06-26
• Last Update Posted: 2024-06-26
• Study Start: 2024-06-28
• Primary Completion: 2024-06-30
• Study Completion: 2024-08-25

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 900

Inclusion Criteria

• Being over 18 years old
• Knowing Turkish, agreeing to participate in the research
• Being diagnosed with cancer, regardless of the type of cancer
• Starting an intravenous chemotherapy treatment regimen after diagnosis
• Those who receive their treatment in 21-day periods to ensure equality in application frequencies.
• Able to use virtual reality glasses
• People without hearing or visual impairment are included

Exclusion Criteria

• Anyone with any visual or hearing impairment
• The patient does not know the diagnosis of cancer, has been diagnosed with cancer but has not received treatment or has completed the cure.
• Those with brain tumor or brain metastasis are not included.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Virtual Reality Glasses	3 month	Virtual Reality Glasses Used in Cancer Patients Will Reduce Anxiety Score on the Visual Analogue Scale in 3 Months